IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation
Cerebrovascular Diseases · 2024
DOI: 10.1159/000540552 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cerebrovascular Diseases, 2024. Verfasst von Kosmas Macha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: Anticoagulants, Fibrinolytic Agents, Ischemic Stroke, Thrombolytic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
IV thrombolysis (IVT) is established in the unknown or extended time window based on multimodal imaging. Further, increasing evidence exists regarding IVT in patients on oral anticoagulation including direct oral anticoagulants (DOACs). However, data on IVT in ischemic stroke patients on oral anticoagulation with unknown time of stroke onset are sparse.
Methods
This study bases on the longitudinal cohort study Stroke Research Consortium in Northern Bavaria (STAMINA; ClinicalTrials.gov Identifier: NCT04357899). Acute ischemic stroke patients treated with IVT in the unknown or extended time window from January 2015 to December 2019 were included. Patient selection was based on multimodal CT or MRI. Patients on oral anticoagulation (vitamin-K antagonist [VKA] or DOAC within 48 h) were eligible for IVT based on INR measurement (VKA) or plasma levels (DOAC) according to an institutional protocol. Primary outcomes were the incidence of any and symptomatic intracranial hemorrhage.
Results
Of 170 ischemic stroke patients treated with IVT in the unknown or extended time window, 151 had no oral anticoagulation at stroke onset and 19 were on oral anticoagulation (6 on VKA and 13 on DOAC). The risk of symptomatic ICH according to ECASS II criteria was similar between the patients with and without oral anticoagulation (1 [5.3%] vs. 4 [2.7%], p = 0.453). After adjustment for confounding factors, pre-medication with oral anticoagulation was not associated with symptomatic ICH (aOR 1.02 [0.09–11.02], p = 0.988).
Conclusion
IVT for ischemic stroke with unknown onset appeared safe in selected patients on oral anticoagulation with both DOAC and VKA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
- Department of Neuroradiology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Zitieren
APA
Macha, K., Sembill, J. A., Muehlen, I., Engelhorn, T., Doerfler, A., Schwab, S., & Kallmünzer, B. (2024). IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation. Cerebrovascular Diseases. https://doi.org/10.1159/000540552
Vancouver
Macha K, Sembill JA, Muehlen I, Engelhorn T, Doerfler A, Schwab S, et al. IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation. Cerebrovascular Diseases. 2024. doi:10.1159/000540552
BibTeX
@article{Macha2024,
author = {Macha, Kosmas and Sembill, Jochen A and Muehlen, Iris and Engelhorn, Tobias and Doerfler, Arnd and Schwab, Stefan and Kallmünzer, Bernd},
title = {IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation},
journal = {Cerebrovascular Diseases},
year = {2024},
doi = {10.1159/000540552}
}
EUVIMED